E
Eupraxia Pharmaceuticals Inc. EPRX.TO
TSX
Recommendation
Sell
Prev Close
$4.70
Volume
--
Avg Vol (90D)
26,540
Market Cap
$117.22M
Dividend & Yield
--
52-Week Range
$3.07 - $6.49
P/E (TTM)
--
EPS (TTM)
-$0.9864
My Lists My Alerts
Weiss Ratings EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Very Weak
Efficiency Index Very Weak
Solvency Index Good
Total Return Index Fair
Volatility Index Weak
Beta / Standard Deviation EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta 0.54
Price History EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return 10.89%
30-Day Total Return 21.54%
60-Day Total Return 34.43%
90-Day Total Return 16.09%
Year to Date Total Return 27.80%
1-Year Total Return 44.67%
2-Year Total Return 33.80%
3-Year Total Return 159.09%
5-Year Total Return --
52-Week High % Change -27.58%
52-Week Low % Change 53.09%
Price EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $6.49
52-Week Low Price $3.07
52-Week Low Price (Date) Oct 22, 2024
52-Week High Price (Date) Feb 26, 2025
Valuation EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 117.22M
Enterprise Value 114.33M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.99
Earnings Per Share Growth -15.34%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) 98.53
Enterprise Value/Revenue (TTM) --
Price $5.70
Enterprise Value/EBITDA (TTM) -3.34
Enterprise Value/EBIT -4.23
Market Cap Category Micro Cap
Dividends and Shares EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 35.64M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 250 590 3968
Address 2067 Cadboro Bay Road Victoria, BC V8R 5G4
Website www.eupraxiapharma.com
Country Canada
Year Founded 2011
Profitability EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -61.14%
Return on Equity --
Income Statement EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -34.27M
EBIT (TTM) -27.00M
Net Income (TTM) -25.50M
Net Income Avl. to Common (TTM) -25.50M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 28.99%
EPS Diluted (TTM) -0.99
EPS Diluted Growth (Q YOY) -17.84%
Balance Sheet EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 33.10M
Cash Per Share (Q) $0.93
Total Current Assets (Q) 34.44M
Total Preferred Equity (Q) 31.71
Total Equity (Q) 31.84M
Current Ratio (Q) 11.096
Book Value Per Share (Q) $0.05
Total Assets (Q) 34.94M
Total Current Liabilities (Q) 3.10M
Total Debt (Q) 71.90K
Total Liabilities (Q) 3.10M
Total Common Equity (Q) 1.70M
Cash Flow EPRX.TO - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) -75.20K
Cash from Financing (TTM) 45.78M
Net Change in Cash (TTM) 13.76M
Levered Free Cash Flow (TTM) -27.40M
Cash from Operations (TTM) -29.99M
Weiss Ratings